Cytokinetics Stock Target Price and Analyst Consensus
| CYTK Stock | USD 47.67 2.19 4.39% |
The current analyst and expert consensus on Cytokinetics is Strong Buy with 8 buy recommendations. The current projected Cytokinetics target price consensus is 62.27, with 19 analyst opinions. Cytokinetics buy-or-sell recommendation module provides average expert sentiment on the projected Cytokinetics target price to derive its highest and lowest estimates based on target price estimated volatility of 2.5088. Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
Lowest Forecast 56.67 | Highest Forecast 69.12 | Target Price 62.27 |
Cytokinetics |
It's important to approach Cytokinetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Cytokinetics Target Price Consensus
Cytokinetics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Cytokinetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 19 | Strong Buy |
Most Cytokinetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Cytokinetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Cytokinetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCytokinetics Target Price Projection
Cytokinetics' current and average target prices are 47.67 and 62.27, respectively. The current price of Cytokinetics is the price at which Cytokinetics is currently trading. On the other hand, Cytokinetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Cytokinetics Market Quote on 22nd of November 2024
Target Price
Analyst Consensus On Cytokinetics Target Price
Cytokinetics Analyst Ratings
Cytokinetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Cytokinetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Cytokinetics' financials, market performance, and future outlook by experienced professionals. Cytokinetics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Cytokinetics price targets
Cytokinetics' stock target price is an estimate of its future price, usually made by analysts. Using Cytokinetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Cytokinetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cytokinetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Cytokinetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cytokinetics is a key component of Cytokinetics valuation and have some predictive power on the future returns of a Cytokinetics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 200 shares | |
 | Momentum Invested few shares | |
 | ESG Investing Invested few shares | |
 | Business Services Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Disruptive Technologies Invested few shares | |
 | Corona Opportunity Invested few shares | |
 | Defense Sold few shares | |
 | Artificial Intelligence Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Investor Favorites Invested over 40 shares | |
 | Warren Buffett Holdings Invested few shares |
Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.